These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 948350)

  • 1. Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium.
    Schuh FR
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 293(1):11-3. PubMed ID: 948350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ketamine on human plasma cholinesterase.
    Schuh FT
    Br J Anaesth; 1975 Dec; 47(12):1315-9. PubMed ID: 1218172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical studies of human plasma cholinesterase].
    Nakao H
    Masui; 1977 May; 26(5):534-41. PubMed ID: 560501
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative analysis of sensitivity of cholinesterases of different origin to reversible bis-onium inhibitors].
    Moralev SN; Rozengard EV
    Zh Evol Biokhim Fiziol; 2008; 44(4):352-64. PubMed ID: 18767551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the inhibition of cholinesterases by pancuronium (author's transl)].
    Schuh FT
    Anaesthesist; 1977 Mar; 26(3):125-9. PubMed ID: 855909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1975 Aug; 47(8):885-8. PubMed ID: 1201167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of cholinesterases by aziridinium derivatives of polymethylene bischloroethylamines].
    Volkova RI; Kochetova LM
    Bioorg Khim; 1983 Jul; 9(7):926-35. PubMed ID: 6679787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the cholinesterase inhibiting properties of two pyrrolidine derivatives.
    Schuh FT
    Arzneimittelforschung; 1977; 27(12):2271-3. PubMed ID: 580040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of anticholinesterase activity in reversible inhibitors of cholinesterase hydrolysis].
    Brestkin AP; Kuznetsova LP; Rozengart EV
    Ukr Biokhim Zh (1978); 1994; 66(1):66-72. PubMed ID: 7974841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.
    Rang HP; Rylett RJ
    Br J Pharmacol; 1984 Mar; 81(3):519-31. PubMed ID: 6141831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
    Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antagonist action of hexamethonium on acetylcholinesterase inhibition by tetrapropylammonium ion].
    Désiré B; Blanchet G; Philibert H
    C R Acad Hebd Seances Acad Sci D; 1974 Feb; 278(9):1273-6. PubMed ID: 4211064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative analysis of sensitivity of cholinesterases of various origin to monoonium reversible inhibitors].
    Moralev SN; Rozengart EV
    Zh Evol Biokhim Fiziol; 2007; 43(3):223-39. PubMed ID: 17725026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interaction of propanidid and suxamethonium with pooled human plasma cholinesterase. A kinetic study.
    Taussig PE; Stojak HE; Bennett NR
    Br J Anaesth; 1979 Mar; 51(3):181-6. PubMed ID: 435340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CHOLINESTERASE INHIBITORS IN ANESTHESIA, WITH SPECIAL REFERENCE TO HEXAFLUORENIUM (MYLAXEN)].
    VAN HEMERTV
    Ned Tijdschr Geneeskd; 1964 Oct; 108():1931-2. PubMed ID: 14242486
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium.
    Scaf AH; van den Akker J; Westenberg HG
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the molecular mechanism of action of galanthamine, an antagonist of nondepolarizing muscle relaxants (author's transl)].
    Schuh FT
    Anaesthesist; 1976 Sep; 25(9):444-8. PubMed ID: 135519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of suxamethonium-induced changes in serum potassium concentration by hexafluorenium. Is their combined use justified?
    Radnay PA; Badola RP; Dalsania A; El-Gaweet EI; Duncalf D
    Br J Anaesth; 1979 May; 51(5):447-51. PubMed ID: 444345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of alkane-bis-onium compounds upon the activity of the AchE and upon its inhibition by DFP.
    Lüllmann H; Ohnesorge FK; Tonner HD; Wassermann O; Ziegler A
    Biochem Pharmacol; 1971 Oct; 20(10):2579-86. PubMed ID: 5114499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.